Peer Review History: Drug Repurposing for COVID-19: Current Status of Potential Therapeutics

Editor(s):

(1) Prof. Syed A. A. Rizvi, College of Biomedical Sciences, Larkin University, USA.

(2) Dr. Erich Cosmi, University of Padua, Italy.

Reviewers:

(1) Şahan Saygi, Near East University, North Cyprus.

(2) Ritesh Ramesh Popat, Dr Rajendra Gode College of Pharmacy, India.

(3) Jimishaben D Kher, Laxminarayan Dev College of Pharmacy, India.

(4) Simon Patching, School of Biomedical Sciences, University of Leeds, UK.

Additional Reviewers:

 

Additional Reviewers: (Comments received after deadline)

(1) Jerry A. Darsey, University of Arkansas at Little Rock, USA.

Open Peer Review Policy: Click Here

Specific Comment:

Average Peer review marks at initial stage: 8.62/10

Average Peer review marks at publication stage: 9/10

Peer Review History:


Stage 1 | Original Manuscript | File 1 | NA


Stage 2 | Peer review report_1 (Şahan Saygi, North Cyprus) | File 1 | NA


Stage 2 | Peer review report_2 (Ritesh Ramesh Popat, India) | File 1 | NA


Stage 2 | Peer review report_3 (Jimishaben D Kher, India) | File 1 | NA


Stage 2 | Peer review report_4 (Simon Patching, UK) | File 1 | NA


Stage 2 | Revised_MS_v1_and_Feedback_v1 | File 1 | File 2


Stage 3 | Comment_Editor_1_v1 | File 1 | NA


Stage 3 | Comment_Editor_2_v1 | File 1 | NA


Posted in Review History.